Hinge Health unveils new FDA-cleared wireless pain relief device

Hinge Health announced that it launched its Enso 3 FDA-cleared wireless device for reducing musculoskeletal pain.

San Francisco-based Hinge designed the device to deliver electrical nerve stimulation for non-invasive, non-addictive pain relief within minutes. The company plans to start the first shipments of the new Enso device this month. It then expects wider availability to all new Hinge Health members starting in 2025.

The new Enso.3 device features reimagined hardware with new colors, finish and materials. Small and light, Enso 3 attaches to the skin with a reusable gel pad for comfort before exercise therapy or during daily activities affected by pain.

Hinge also introduced new, clinically proven electrical waveforms customized to different body parts and pain levels. The company programmed the patterns of electrical signals through software to relieve pain. It also features two new waveforms targeting smaller muscles, also aiding people with more sensitivity.

Sign up for Blog Updates